CRUK
Cancer Research UK, Guardant Health Ink Research, Data Sharing Partnership
The collaboration aims to help accelerate the discovery and development of cancer drugs and diagnostics through ongoing and potentially new clinical trials.
Twist Bioscience Licenses Antibody Libraries to Cancer Research Horizons
Cancer Research Horizons will license the entire Twist Biopharma Solutions "Library of Libraries," a collection of synthesized antibody libraries.
Personalis MRD Assays to Support UK's TRACERx ctDNA Monitoring Study
The ongoing lung cancer study, which has employed other assays in the past, will now use the Personalis NeXT Personal platform to monitor for recurrence after surgery.
Cancer Research UK, Abcam Partner to Develop Custom Antibodies for Cancer Research
Abcam will develop custom protein-based reagents for
AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials
ArcherDx will develop sequencing-based circulating tumor DNA assays for use in AstraZeneca's recently launched Phase III MERMAID-1 trial of durvalumab (Imfinzi).